Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
常染色体显性多囊肾病心脏功能障碍的驱动机制
基本信息
- 批准号:10443441
- 负责人:
- 金额:$ 40.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-15 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAction PotentialsAffectAgeAllelesAutomobile DrivingAutosomal Dominant Polycystic KidneyBiochemicalCa(2+)-Transporting ATPaseCalciumCardiacCardiac MyocytesCardiovascular DiseasesCause of DeathCellsClinicalComplementCyclic AMPCyclic AMP-Dependent Protein KinasesDataDoseEconomic BurdenElectrophysiology (science)EventExhibitsFunctional disorderGene MutationGenesHeartHeart DiseasesHeart failureHereditary DiseaseHistologicHumanHypertensionImpairmentIn VitroIndividualInterventionKidneyKidney DiseasesKidney FailureKnock-inKv channel-interacting protein 2LeftLongevityMethodsModelingMolecularMonitorMorbidity - disease rateMusMutationMyocardial dysfunctionNG-Nitroarginine Methyl EsterPathway interactionsPatientsPersonsPharmacologyPotassiumPotassium ChannelPredispositionProcessProteinsQuality of lifeRegulationReportingRoleSarcoplasmic ReticulumSignal TransductionTechniquesTestingTimeVentricularVentricular Dysfunctionbasecomorbiditydefined contributionhealth care economicsheart functionimprovedin vivoinduced pluripotent stem cell derived cardiomyocytesinsightkidney cellkidney dysfunctionknock-downmortalitymouse modelmutantnoveloverexpressionphospholambanpolycystic kidney disease 1 proteinrenal epitheliumsarcoplasmic reticulum calcium ATPasesmall molecule
项目摘要
Cardiovascular disease is a major cause of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Characterized by progressive renal dysfunction, ADPKD imposes very significant healthcare and economic burdens. It has commonly been assumed that progressive renal impairment promotes cardiac disease; however, our preliminary data suggest that cardiac dysfunction originates in cardiomyocytes and manifests prior to renal failure in ADPKD. Recent clinical evidence supports our findings by showing that ADPKD patients exhibit ventricular dysfunction before the onset of renal failure, even in non-hypertensive individuals. Mutations in the gene encoding Polycystin-1 (PC1) occur in 85% of patients and are responsible for the most severe cases. Importantly, PC1 is expressed in cardiomyocytes, yet its role(s) there is(are) poorly understood. We propose that the mutant PC1 – in a cardiomyocyte-autonomous fashion – initiates and drives heart disease in ADPKD, independent of renal failure. Our data show that PC1 cardiomyocyte-specific deletion promotes systolic and diastolic dysfunction in mice. Furthermore, using a mouse model harboring a clinically established ADPKD-causing PC1 mutation (RC allele), we provide evidence of impaired calcium-cycling and contractility at the cardiomyocyte level, which occur before the onset of renal failure. Heterozygous RC/+ young mice manifest alterations in calcium handling/contractility in isolated cardiomyocytes, which correlate with reduced left ventricular global longitudinal strain and diastolic dysfunction. We discovered that PC1 regulates action potential duration via Kv channel current regulation. PC1 ablation shortens action potential duration and impairs both calcium transients and contractility in cardiomyocytes. Additionally, PC1 deletion impairs sarcoplasmic reticulum (SR) calcium loading through reduced SR calcium-ATPase (SERCA) activity. These data have led us to hypothesize that ADPKD-causing PC1 mutations disrupt PC1 actions in cardiomyocytes, impair cardiac function and predispose the heart to hypertension-induced heart failure, independent of renal dysfunction. To test this hypothesis, we propose three aims: 1) determine how PC1 mutations affect action potentials and Kv channel activity and impinge on calcium handling and contractility. 2) elucidate mechanisms whereby PC1 regulates SR calcium loading and SERCA to maintain cardiomyocyte function and test the impact of ADPKD mutations in PC1 on these events. 3) determine in vivo whether alterations in PC1 signaling in cardiomyocytes drive cardiac dysfunction and predispose the heart to hypertension-induced heart failure. Completion of our studies will provide paradigm-shifting information regarding the role of cardiomyocyte-autonomous events driving heart disease in ADPKD, the leading cause of death in these patients.
心血管疾病是常染色体显性遗传性多囊肾病(ADPKD)患者发病和死亡的主要原因。以进行性肾功能不全为特征的ADPKD造成了非常严重的医疗保健和经济负担。通常认为进行性肾损害促进心脏病;然而,我们的初步数据表明,心功能不全起源于心肌细胞,并在ADPKD肾衰竭之前表现出来。最近的临床证据支持我们的研究结果,显示ADPKD患者在肾衰竭发作前表现出心室功能障碍,即使在非高血压个体中也是如此。编码多囊蛋白-1(PC 1)的基因突变发生在85%的患者中,并且是最严重病例的原因。重要的是,PC 1在心肌细胞中表达,但其作用却知之甚少。我们认为突变型PC 1以心肌细胞自主的方式启动并驱动ADPKD患者的心脏病,与肾衰竭无关。我们的数据表明,PC 1心肌细胞特异性缺失促进小鼠的收缩和舒张功能障碍。此外,使用一个小鼠模型窝藏一个临床上建立的ADPKD引起的PC 1突变(RC等位基因),我们提供的证据表明,受损的钙循环和心肌细胞水平的收缩力,这发生在肾功能衰竭发作之前。杂合子RC/+年轻小鼠表现出在离体心肌细胞中钙处理/收缩性的改变,这与左心室整体纵向应变和舒张功能障碍的降低相关。我们发现,PC 1通过Kv通道电流调节来调节动作电位时程。PC 1消融缩短了动作电位时程,并损害了心肌细胞的钙瞬变和收缩性。此外,PC 1缺失通过降低肌浆网(SR)钙-ATP酶(SERCA)活性损害SR钙负荷。这些数据使我们假设ADPKD引起的PC 1突变破坏了心肌细胞中的PC 1作用,损害了心脏功能,使心脏易患高血压诱导的心力衰竭,与肾功能不全无关。为了验证这一假设,我们提出了三个目标:1)确定PC 1突变如何影响动作电位和Kv通道活性,并影响钙处理和收缩性。2)阐明PC 1调节SR钙负荷和SERCA以维持心肌细胞功能的机制,并测试PC 1中ADPKD突变对这些事件的影响。3)在体内确定心肌细胞中PC 1信号传导的改变是否驱动心功能障碍并使心脏易于发生高血压诱导的心力衰竭。我们研究的完成将提供关于心肌细胞自主事件驱动心脏病在ADPKD中的作用的范式转变信息,ADPKD是这些患者死亡的主要原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francisco Altamirano其他文献
Francisco Altamirano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francisco Altamirano', 18)}}的其他基金
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
心房颤动的心脏自主激活触发因素和基质
- 批准号:
10636441 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
常染色体显性多囊肾病心脏功能障碍的驱动机制
- 批准号:
10618336 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
相似海外基金
Kilohertz volumetric imaging of neuronal action potentials in awake behaving mice
清醒行为小鼠神经元动作电位的千赫兹体积成像
- 批准号:
10515267 - 财政年份:2022
- 资助金额:
$ 40.38万 - 项目类别:
Signal processing in horizontal cells of the mammalian retina – coding of visual information by calcium and sodium action potentials
哺乳动物视网膜水平细胞的信号处理 â 通过钙和钠动作电位编码视觉信息
- 批准号:
422915148 - 财政年份:2019
- 资助金额:
$ 40.38万 - 项目类别:
Research Grants
CAREER: Resolving action potentials and high-density neural signals from the surface of the brain
职业:解析来自大脑表面的动作电位和高密度神经信号
- 批准号:
1752274 - 财政年份:2018
- 资助金额:
$ 40.38万 - 项目类别:
Continuing Grant
Development of Nanosheet-Based Wireless Probes for Multi-Simultaneous Monitoring of Action Potentials and Neurotransmitters
开发基于纳米片的无线探针,用于同时监测动作电位和神经递质
- 批准号:
18H03539 - 财政年份:2018
- 资助金额:
$ 40.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Population Imaging of Action Potentials by Novel Two-Photon Microscopes and Genetically Encoded Voltage Indicators
通过新型双光子显微镜和基因编码电压指示器对动作电位进行群体成像
- 批准号:
9588470 - 财政年份:2018
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
- 批准号:
10009724 - 财政年份:2018
- 资助金额:
$ 40.38万 - 项目类别:
Enhanced quantitative imaging of compound action potentials in multi-fascicular peripheral nerve with fast neural Electrical Impedance Tomography enabled by 3D multi-plane softening bioelectronics
通过 3D 多平面软化生物电子学实现快速神经电阻抗断层扫描,增强多束周围神经复合动作电位的定量成像
- 批准号:
10467225 - 财政年份:2018
- 资助金额:
$ 40.38万 - 项目类别:
Fast high-resolution deep photoacoustic tomography of action potentials in brains
大脑动作电位的快速高分辨率深度光声断层扫描
- 批准号:
9423398 - 财政年份:2017
- 资助金额:
$ 40.38万 - 项目类别:
NeuroGrid: a scalable system for large-scale recording of action potentials from the brain surface
NeuroGrid:用于大规模记录大脑表面动作电位的可扩展系统
- 批准号:
9357409 - 财政年份:2016
- 资助金额:
$ 40.38万 - 项目类别:
Noval regulatory mechanisms of axonal action potentials
轴突动作电位的新调节机制
- 批准号:
16K07006 - 财政年份:2016
- 资助金额:
$ 40.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)